Please assess the completion status of the following clinical trial:

Trial Title: An Open-Label Study Of Lamictal In Neurotic Excoriation

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* men and women age 18-65~* current diagnosis of neurotic excoriation~Exclusion Criteria:~* unstable medical illness or clinically significant abnormalities on prestudy laboratory tests or physical examination~* history of seizures~* myocardial infarction within 6 months~* current pregnancy or lactation, or inadequate contraception in women of childbearing potential~* a need for medication other than Lamictal with possible psychotropic effects or unfavorable interactions with Lamictal~* clinically significant suicidality~* lifetime history of DSM-IV bipolar disorder type I, dementia, or schizophrenia or any other DSM-IV psychotic disorder~* current or recent (past 3 months) DSM-IV substance abuse or dependence~* illegal substance use within 2 weeks of study initiation~* initiation of psychotherapy or behavior therapy from a mental health professional within 3 months prior to study baseline~* previous treatment with Lamictal~* treatment with investigational medication or depot neuroleptics within 3 months, with fluoxetine within 6 weeks, or with other psychotropics within 2 weeks prior to study baseline~* current treatment with an anti-epileptic medication and~* patients who have previously been diagnosed with a medical condition that cause skin itchiness (e.g. liver, kidney, and blood diseases, etopic allergies)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).